Proteomics International Laboratories Overview

  • Year Founded
  • 2001

Year Founded

  • Status
  • Public

  • Stock Symbol
  • PIQ

Stock Symbol

  • Investments
  • 1

  • Share Price
  • $0.06
  • (As of Thursday Closing)

Proteomics International Laboratories General Information

Description

Proteomics International Laboratories Ltd is a medical technology company specializing in proteomics and precision diagnostics. The company develops and commercializes blood-based tests designed to support earlier and more precise diagnosis and risk assessment. It has established accredited laboratory facilities in Australia and the United States and is headquartered in Perth, Western Australia. Its products portfolio Promarker D, Promarker Eso, Promarker Endo, and OxiDx. It operates in single segment.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • Level 1, 6 Verdun Street
  • Nedlands
  • Perth, Western Australia 6009
  • Australia
+61 (08)
Primary Industry
Diagnostic Equipment
Other Industries
Drug Discovery
Biotechnology
Stock Exchange
ASX
Vertical(s)
Corporate Office
  • Level 1, 6 Verdun Street
  • Nedlands
  • Perth, Western Australia 6009
  • Australia
+61 (08)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Proteomics International Laboratories Stock Performance

As of 19-Nov-2026, Proteomics International Laboratories’s stock price is $0.06. Its current market cap is $10.5M with 165M shares.

(As of Thursday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.06 $0.06 $0.06 - $0.58 $10.5M 165M 120K

Proteomics International Laboratories Financials Summary

As of 30-Sep-2026, Proteomics International Laboratories has a trailing 12-month revenue of null.

In Thousands,
USD
TTM 30-Sep-2026 FY 2026 30-Jun-2026 FY 2025 30-Jun-2025 FY 2024 30-Jun-2024
EV 13,210 7,942 31,279 73,247
Revenue 188 621 585
EBITDA (5,422) (4,974) (3,941)
Net Income (5,799) (5,250) (4,179)
Total Assets 6,113 9,655 7,269
Total Debt 228 181 211
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Proteomics International Laboratories Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Proteomics International Laboratories‘s full profile, request access.

Request a free trial

Proteomics International Laboratories Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Proteomics International Laboratories Ltd is a medical technology company specializing in proteomics and precision diagn
Diagnostic Equipment
Perth, Australia

Schertz, TX
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Proteomics International Laboratories Competitors (1)

One of Proteomics International Laboratories’s competitors is Evestra, a Venture Capital-Backed company based in Schertz, TX.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Evestra Venture Capital-Backed Schertz, TX
You’re viewing 1 of 1 competitors. Get the full list »

Proteomics International Laboratories Patents

Proteomics International Laboratories Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
AU-2024900353-A0 Airway disease biomarkers Pending 14-Feb-2024
AU-2023900328-A0 Airway disease biomarkers Pending 10-Feb-2023
AU-2022900265-A0 Airway disease biomarkers Pending 09-Feb-2022
AU-2020900805-A0 Endometriosis biomarkers Pending 16-Mar-2020
AU-2021237128-A1 Endometriosis biomarkers Active 16-Mar-2020 G01N33/689
To view Proteomics International Laboratories’s complete patent history, request access »

Proteomics International Laboratories Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Proteomics International Laboratories‘s full profile, request access.

Request a free trial

Proteomics International Laboratories Investments (1)

Proteomics International Laboratories’s most recent deal was a Secondary Transaction - Private with Agilex Biolabs for . The deal was made on 05-Mar-2018.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Agilex Biolabs 05-Mar-2018 Secondary Transaction - Private Other Pharmaceuticals and Biotechnology
To view Proteomics International Laboratories’s complete investments history, request access »

Proteomics International Laboratories ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Commercial Services

Industry

Rank

Percentile

Business Support Services

Subindustry

Rank

Percentile

To view Proteomics International Laboratories’s complete esg history, request access »

Proteomics International Laboratories Exits (1)

Proteomics International Laboratories’s most recent exit was on 05-Mar-2018 from Agilex Biolabs. The exit was categorized as .

Company Name Exit Date Exit Type Exit Size Status Buyers
Agilex Biolabs 05-Mar-2018 Completed
To view Proteomics International Laboratories’s complete exits history, request access »

Proteomics International Laboratories FAQs

  • When was Proteomics International Laboratories founded?

    Proteomics International Laboratories was founded in 2001.

  • Where is Proteomics International Laboratories headquartered?

    Proteomics International Laboratories is headquartered in Perth, Australia.

  • What industry is Proteomics International Laboratories in?

    Proteomics International Laboratories’s primary industry is Diagnostic Equipment.

  • Is Proteomics International Laboratories a private or public company?

    Proteomics International Laboratories is a Public company.

  • What is Proteomics International Laboratories’s stock symbol?

    The ticker symbol for Proteomics International Laboratories is PIQ.

  • What is the current stock price of Proteomics International Laboratories?

    As of 19-Nov-2026 the stock price of Proteomics International Laboratories is $0.06.

  • What is the current market cap of Proteomics International Laboratories?

    The current market capitalization of Proteomics International Laboratories is $10.5M.

  • Who are Proteomics International Laboratories’s competitors?

    Evestra is a competitor of Proteomics International Laboratories.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process